Trends in the theory that inflammation plays a causal role in tendinopathy: a systematic review and quantitative analysis of published reviews

Background/aims The contribution of inflammation to tendinopathy has been debated in the scientific literature. Several factors may contribute to this lack of clarity, including inconsistent definitions of inflammation. We hypothesised that the adoption and/or rejection of a causal link between inflammation and tendinopathy varied as a function of the ‘inflammatory component’ (eg, immune cell and molecular mediators included in published reviews). Methods Twenty data items were collected from each review to determine conclusions about the role of inflammation in tendinopathy, specific definitions of the ‘inflammatory component,’ quality of the review and other potential correlates. Associations between correlates and a review’s conclusion about the role of inflammation in tendinopathy were tested using binomial logistic regression. The database searches retrieved 2261 unique publications: 137 fulfilled inclusion criteria after full text screenings. Results There has been little support for an inflammatory component to tendinopathy until recently (2012–2015). Prior to 2012, the majority of published reviews did not discuss monocytes, macrophages or lymphocytes in tendinopathy; rather they focused on the lack of neutrophils, often referred to as ‘the inflammatory infiltrate’, or immune cells were not discussed. Reviews including monocytes and lymphocytes in their discussions were 5.23 times more likely to conclude inflammation was important than reviews that did not, p<0.001. Conclusions Data collected show growing support for an inflammatory component to tendinopathy, particularly among high-quality reviews and those that used more robust definitions of inflammation. This finding may have implications for explaining dissonance in the literature regarding a causal role for inflammation in the pathogenesis of tendinopathy.

[1]  Graham Wells,et al.  Chronic inflammation is a feature of Achilles tendinopathy and rupture , 2017, British Journal of Sports Medicine.

[2]  S. Dakin,et al.  Differential expression of alarmins—S100A9, IL-33, HMGB1 and HIF-1α in supraspinatus tendinopathy before and after treatment , 2017, BMJ Open Sport & Exercise Medicine.

[3]  S. Dakin,et al.  Persistent stromal fibroblast activation is present in chronic tendinopathy , 2017, Arthritis Research & Therapy.

[4]  Jörg Spörri,et al.  Equipment designed to reduce risk of severe traumatic injuries in alpine ski racing: constructive collaboration between the International Ski Federation, industry and science , 2015, British Journal of Sports Medicine.

[5]  Udo Oppermann,et al.  Inflammation activation and resolution in human tendon disease , 2015, Science Translational Medicine.

[6]  S. Dakin,et al.  Are inflammatory cells increased in painful human tendinopathy? A systematic review , 2015, British Journal of Sports Medicine.

[7]  G. Myer,et al.  Citius, Altius, Fortius: beneficial effects of resistance training for young athletes: Narrative review , 2015, British Journal of Sports Medicine.

[8]  Y. Rui,et al.  Alterations of tendons in diabetes mellitus: what are the current findings? , 2015, International Orthopaedics.

[9]  E. Samaila,et al.  The pathogenesis of Achilles tendinopathy: a systematic review. , 2014, Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons.

[10]  Rikesh Patel,et al.  Stroma: fertile soil for inflammation. , 2014, Best practice & research. Clinical rheumatology.

[11]  J. Cook,et al.  Fluoroquinolones and tendinopathy: a guide for athletes and sports clinicians and a systematic review of the literature. , 2014, Journal of athletic training.

[12]  P. Rochon,et al.  Tendon Injury and Fluoroquinolone Use: A Systematic Review , 2013, Drug Safety.

[13]  A. Scott,et al.  Tendons – time to revisit inflammation , 2013, British Journal of Sports Medicine.

[14]  N. Bureau Calcific Tendinopathy of the Shoulder , 2013, Seminars in Musculoskeletal Radiology.

[15]  A. Carr,et al.  A systematic review of the histological and molecular changes in rotator cuff disease , 2012, Bone & joint research.

[16]  F. Kaleagasioglu,et al.  Fluoroquinolone-induced tendinopathy: etiology and preventive measures. , 2012, The Tohoku journal of experimental medicine.

[17]  R. R. D. de Oliveira,et al.  Alterations of tendons in patients with diabetes mellitus: a systematic review , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[18]  I. van den Akker-Scheek,et al.  Risk factors for patellar tendinopathy: a systematic review of the literature , 2011, British Journal of Sports Medicine.

[19]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[20]  David Moher,et al.  Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews , 2007, BMC medical research methodology.

[21]  Ulrike Dapp,et al.  Development, feasibility and performance of a health risk appraisal questionnaire for older persons , 2007, BMC medical research methodology.

[22]  A. Wilson,et al.  Current concepts in the management of tendon disorders. , 2006, Rheumatology.

[23]  A. Melhus Fluoroquinolones and tendon disorders , 2005, Expert opinion on drug safety.

[24]  T. Hamada,et al.  Pathologic Evidence of Degeneration as a Primary Cause of Rotator Cuff Tear , 2003, Clinical orthopaedics and related research.

[25]  G. Zhanel,et al.  Fluoroquinolone-associated tendinopathy: a critical review of the literature. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  P. Kannus,et al.  Time to abandon the “tendinitis” myth , 2002, BMJ : British Medical Journal.

[27]  Karim M. Khan,et al.  Histopathology of Common Tendinopathies , 1999, Sports medicine.

[28]  K. Khan,et al.  Tendinopathy: an Achilles' heel for athletes and clinicians. , 1998 .

[29]  Pekka Kannus,et al.  Human Tendons: Anatomy, Physiology, and Pathology , 1997 .

[30]  A. Gad,et al.  Tendon pathology in long-standing achillodynia. Biopsy findings in 40 patients. , 1997, Acta orthopaedica Scandinavica.

[31]  A. Rausing,et al.  Chronic Achilles Tendinopathy: A Survey of Surgical and Histopathologic Findings Mats , 1995, Clinical orthopaedics and related research.

[32]  J. Weiler Medical modifiers of sports injury. The use of nonsteroidal anti-inflammatory drugs (NSAIDs) in sports soft-tissue injury. , 1992, Clinics in sports medicine.

[33]  G. Puddu,et al.  A classification of achilles tendon disease , 1976, The American journal of sports medicine.

[34]  R. Schlienger,et al.  Corticosteroid-Associated Tendinopathies , 2005, Drug safety.

[35]  H. Uhthoff,et al.  Calcifying tendinitis , 2004, International Orthopaedics.

[36]  J. Russell,et al.  Anabolic steroid-induced tendon pathology: a review of the literature. , 1991, Medicine and science in sports and exercise.

[37]  S. De seze,et al.  [Calcifying tendinitis]. , 1970, Rhumatologie.